AHCO — AdaptHealth Corp. stock price, charts and financials

Latest market price

6.71

-4.12-38.04%

Overview Short InterestFilings

AHCOQT38AdaptHealth Corp.·NASDAQ

Overview Short InterestFilings

6.71-38.04%

Earnings

Down 38.0% — Trailing quarter EPS missed by 580% while revenue beat by only 3%, indicating severe earnings deterioration.

High confidence

Loading chart...

Signal & projected range

Gap down — mean-reversionHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

BVS-0.37%$13.42 INMD+0.13%$15.37 SIBN-0.05%$18.44 PRCT-0.54%$18.28 SSII-3.04%$3.83 AVNS+0.04%$24.99 CBLL+1.15%$18.52 IRMD+1.71%$93.13

Snapshot

Index	-	P/E	-	EPS (ttm)	-0.59	Insider Own	-	Shs Outstand	136.05M	Perf Week	-40.20%

Market Cap	912.92M	Forward P/E	5.80	EPS next Y	1.16	Insider Trans	4.25%	Shs Float	86.27M	Perf Month	-34.66%

Enterprise Value	2.81B	PEG	-	EPS next Q	-	Inst Own	-	Short Float	9.29%	Perf Quarter	-48.54%

Income	-79.00M	P/S	0.32	EPS this Y	248.89%	Inst Trans	-	Short Ratio	5.49	Perf Half Y	-33.56%

Sales	2.86B	P/B	0.60	EPS next Y	31.68%	ROA	-1.80%	Short Interest	8.01M	Perf YTD	-32.63%

Book/sh	11.13	P/C	19.02	EPS next 5Y	17.24%	ROE	-5.11%	52W High	13.43 -50.04%	Perf Year	-23.31%

Cash/sh	0.35	P/FCF	7.66	EPS past 3/5Y	-	ROIC	5.52%	52W Low	6.14 9.28%	Perf 3Y	-50.63%

Dividend Est.	-	EV/EBITDA	6.09	Sales past 3/5Y	2.98% 25.17%	Gross Margin	5.38%	Volatility	5.28% 4.15%	Perf 5Y	-69.79%

Dividend TTM	-	EV/Sales	0.98	EPS Y/Y TTM	-196.72%	Oper. Margin	7.26%	ATR (14)	0.74	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	0.71	Sales Y/Y TTM	-12.27%	Profit Margin	-2.78%	RSI (14)	20.66	Recom	2.33

Dividend Gr. 3/5Y	-	Current Ratio	0.92	EPS Q/Q	-	SMA20	-35.97%	Beta	1.37	Target Price	14.20

Payout	0.00%	Debt/Eq	1.21	Sales Q/Q	41.38%	SMA50	-34.37%	Rel Volume	11.19	Prev Close	10.83

Employees	10,900	LT Debt/Eq	1.20	Earnings	Nov 03	SMA200	-35.47%	Avg Volume	1.70M	Price	6.71

IPO Date	May 31, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-580.08% 2.91%	Net Debt/EBITDA	4.22	Volume	18,992,347	Change	-38.04%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jul-21-26	Upgrade	Jefferies	Hold → Buy	$11 → $13
Jul-06-26	Reiterated	Robert W. Baird		$18 → $15
May-11-26	Reiterated	RBC Capital	Outperform	$13 → $15
May-06-26	Reiterated	Robert W. Baird		$17 → $18
May-06-26	Reiterated	Canaccord Genuity	Buy	$16
Apr-20-26	Reiterated	Jefferies	Buy	$9.50 → $11
Feb-26-26	Reiterated	Leerink Partners	Outperform	$12
Feb-25-26	Reiterated	RBC Capital	Outperform	$13
Nov-15-24	Reiterated	Truist Securities	Buy	$12
Nov-06-24	Reiterated	Robert W. Baird		$16 → $14

Latest News

Aug-04-26

Aug-04-2601:09PM

AHCO INVESTOR ALERT: Investigation of AdaptHealth Corp. Announced by Holzer & Holzer, LLCglobenewswire.com

11:09AM

AdaptHealth Corp. (AHCO) Q2 2026 Earnings Call Transcriptseekingalpha.com

10:06AM

AdaptHealth Q2 Earnings Call Highlightsmarketbeat.com

07:00AM

AdaptHealth Corp. Announces Second Quarter 2026 Resultsbusinesswire.com

Aug-01-26

Aug-01-2603:41AM

Arrowstreet Capital Limited Partnership Has $10.08 Million Stake in AdaptHealth Corp. $AHCOdefenseworld.net

Jul-29-26

Jul-29-2611:10AM

Cardinal Health (CAH) Stock Looks Pricey Following Its Home Care Deal PushYahoo

Jul-24-26

Jul-24-2604:17PM

3 Small-Cap Stocks That Fall ShortYahoo

Jul-20-26

Jul-20-2605:23PM

Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 millionreuters.com

04:47PM

Cardinal Health To Acquire The Diabetes Health Business Of Adapthealth And, In Its Entirety, Strive Medical For ~$360M In CashBenzinga

04:45PM

Cardinal Health expands home care business with two tuck-in acquisitionsprnewswire.com

04:30PM

AdaptHealth Corp. Enters into Definitive Agreement to Divest Diabetes Health Business to Cardinal Healthbusinesswire.com

Jul-14-26

Jul-14-2604:05PM

AdaptHealth Corp. Announces Second Quarter 2026 Earnings Release Date and Conference Callbusinesswire.com

Jul-06-26

Jul-06-2610:34AM

AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management SystemsBenzinga

Jun-24-26

Jun-24-2607:52PM

AdaptHealth (AHCO) Stock Trades Up, Here Is WhyYahoo

Jun-22-26

Jun-22-2611:47AM

3 of Wall Street’s Favorite Stocks We Find RiskyYahoo

Company

AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	2,861	3,245	3,261	3,200	2,971	2,455	1,056	530	345
Cost of Goods Sold Incl. D&A	2,706	2,676	2,580	2,518	2,553	2,009	899	441	285
Gross Profit	153	569	681	682	417	446	158	89	60
Selling, General and Administrative Excl. Other	386	382	359	190	162	168	89	56	1
Research and Development	0	0	0	0	0	0	0	0	0
Other Operating Expense	-439	0	58	1,090	65	52	-3	4	0
Operating Income	207	186	264	-598	190	226	71	29	-1
Interest Expense	103	106	127	130	109	95	41	39	4
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	-134	-96	-1	5	17	61	-236	-12	8
Net Income Before Taxes	-30	-15	136	-724	98	191	-206	-22	3
Income Taxes	46	51	41	-49	25	33	-12	1	1
Consolidated Net Income	-79	-71	90	-679	69	156	-162	-21	2
Net Income From Continuing Operations	-75	-66	95	-675	73	158	-194	-23	24
Net Income	-79	-71	90	-679	69	156	-162	-21	2
EPS (Recurring)	-0.59	-0.52	0.62	-5.32	0.52	1.12	-1.23	0.17	0.07
EPS (Basic, Before Extraordinaries)	-0.59	-0.52	0.62	-5.32	0.52	1.12	-1.23	0.17	0.07
EPS (Diluted)	-0.59	-0.52	0.61	-5.31	0.50	0.67	-1.23	0.17	0.07
EBITDA	462	504	628	-171	631	544	-82	80	81
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	15.61	—	38.44	36.51	—	64.59	147.16
Price To Sales Ratio	0.32	0.41	0.39	0.31	0.87	1.26	1.85	1.49	0.88
Gross Margin	5.35	17.53	20.88	21.31	14.04	18.17	14.96	16.79	17.39
Operating Margin	7.24	5.73	8.10	-18.69	6.40	9.21	6.72	5.47	-0.29
Net Margin	-2.76	-2.19	2.76	-21.22	2.32	6.35	-15.34	-3.96	0.58
Shares Outstanding	136	135	134	134	134	126	52	72	31
Market Capitalization	913	1,345	1,276	977	2,575	3,082	1,953	791	305
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schuster III Russell E.	Chief Commercial Officer	Jul 01 '26	Sale	10.44	11,275	117,711	125,263	Jul 06
Schuster III Russell E.	Chief Commercial Officer	Jun 01 '26	Sale	10.06	11,275	113,427	136,538	Jun 03
OEP VII GP, L.L.C.	10% Owner	Mar 20 '26	Buy	9.91	447,100	4,431,700	16,312,698	Mar 30
OEP VII GP, L.L.C.	10% Owner	Mar 19 '26	Buy	9.94	727	7,228	15,865,598	Mar 30
OEP VII GP, L.L.C.	10% Owner	Mar 12 '26	Buy	9.73	689,336	6,707,170	15,864,871	Mar 30
OEP VII GP, L.L.C.	10% Owner	Mar 11 '26	Buy	9.73	536,827	5,222,307	15,175,535	Mar 30
OEP VII GP, L.L.C.	10% Owner	Mar 10 '26	Buy	9.73	820,528	7,982,671	14,638,708	Mar 30
CASHIN RICHARD M JR	10% Owner	Mar 20 '26	Buy	9.91	447,100	4,431,700	16,312,698	Mar 23
CASHIN RICHARD M JR	10% Owner	Mar 19 '26	Buy	9.94	727	7,228	15,865,598	Mar 23
Prast Albert A.	Chief Technology Officer	Mar 13 '26	Option Exercise	4.38	89,451	391,795	532,358	Mar 16
CASHIN RICHARD M JR	10% Owner	Mar 12 '26	Buy	9.73	689,336	6,707,170	15,864,871	Mar 12
CASHIN RICHARD M JR	10% Owner	Mar 11 '26	Buy	9.73	536,827	5,222,307	15,175,535	Mar 12
CASHIN RICHARD M JR	10% Owner	Mar 10 '26	Buy	9.73	820,528	7,982,671	14,638,708	Mar 12
WOLF DALE B	Director	Feb 27 '26	Buy	8.96	8,000	71,680	104,235	Mar 03
Rew Richard W. II	CLO and General Counsel	Feb 26 '26	Buy	8.91	5,000	44,550	107,097	Feb 27

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.